BlackRock Advantage Large Cap Core Portfolio ABBV Holdings History
BlackRock Advantage Large Cap Core Portfolio's AbbVie Inc Holding Summary
As of 2025-03-31, BlackRock Series Fund, Inc. held 6,604.00 shares of AbbVie Inc(ABBV), totaling $1.38 Mil. This investment constitutes 0.71% of their stock portfolio, and BlackRock Series Fund, Inc. now holds 0% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2019Q3. And since then BlackRock Advantage Large Cap Core Portfolio has made 7 purchases of ABBV, at an average price of $113.07, for a total of 46,246.00 shares. In addition, there have been 10 sales at an average price of $126.22 for 39,642.00 shares. Based on historical transaction data and ABBV's current price of $189.26, BlackRock Advantage Large Cap Core Portfolio's estimated gain on his ABBV holdings is $1.02 Mil, reflecting a 19.60% gain to date.
BlackRock Advantage Large Cap Core Portfolio ABBV ($189.26) Holding Chart
BlackRock Advantage Large Cap Core Portfolio ABBV ($189.26) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
